This is a molecule-level guide to semaglutide in Newfoundland and Labrador. Rather than focusing on a single brand, I cover how to choose between Ozempic, Wegovy, Rybelsus and the newly launched generic, when Newfoundlanders and Labradorians can now get generic semaglutide at their pharmacy, why compounded semaglutide is not legal in Canada, and what the clinical evidence says. Pricing reflects April 2026 quotes.
If you already know which brand you need, jump to our Ozempic in Newfoundland and Labrador guide for diabetes details or our Wegovy in Newfoundland and Labrador guide for weight-management details. For the full semaglutide overview, see our complete semaglutide guide.
What Semaglutide Means for Newfoundland and Labrador Patients
Semaglutide is the active pharmaceutical ingredient in three Health Canada-approved brand products plus the newly launched generic [1]:
- Ozempic (injectable, 0.25 to 2.0 mg weekly). On-label for type 2 diabetes. Widely prescribed off-label for weight loss. Cash price $250 to $375 per month in Newfoundland and Labrador.
- Wegovy (injectable, 0.25 to 2.4 mg weekly). On-label for chronic weight management (BMI 30+, or 27+ with comorbidity). Cash price $540 to $570 per month. Higher dose, higher price.
- Rybelsus (oral tablet, 3, 7 or 14 mg daily). On-label for type 2 diabetes. The oral formulation. Cash price roughly $250 to $300 per month.
- Generic semaglutide (injectable, launched May 2026 for diabetes). Manufactured by Apotex (Apo-Semaglutide) and Dr. Reddy's, with Sandoz, Teva Canada and others still under Health Canada review. Cash pharmacy price $88 to $120 per month for diabetes doses; $150 to $250 per month for the future 2.4 mg weight-management dose (Wegovy-equivalent), expected in late 2026 or early 2027 pending Health Canada approval.
In Newfoundland and Labrador, the brand you receive depends on your indication (diabetes vs weight management), your prescriber’s preference, public plan coverage and the price your insurance or wallet can absorb. More on each below.
Semaglutide Products Available in Newfoundland and Labrador
Every major pharmacy chain in Newfoundland and Labrador stocks all three brand semaglutide products as of April 2026 [2]. The table below summarizes how each compares for Newfoundlanders and Labradorians.
| Product | Form | Indication | Typical Monthly Cost (April 2026) | Public Plan Status |
|---|---|---|---|---|
| Ozempic | Injectable (0.25 to 2.0 mg) | Type 2 diabetes (off-label for weight loss) | $250 to $375 | NLPDP Special Authorization |
| Wegovy | Injectable (0.25 to 2.4 mg) | Chronic weight management | $540 to $570 | Not covered |
| Rybelsus | Oral tablet (3, 7 or 14 mg) | Type 2 diabetes | $250 to $300 | NLPDP Special Authorization |
| Generic semaglutide | Injectable (various) | Diabetes first, weight management later | $88 to $120 | Under formulary review (2026–2027) |
Choosing Your Semaglutide Product in Newfoundland and Labrador
Here’s a quick decision framework Newfoundlanders and Labradorians can use. Your prescribing clinician makes the final call.
If you have type 2 diabetes
Ozempic is the default because NLPDP lists it as Special Authorization for type 2 diabetes, your co-pay is typically the cheapest of the three brand options, and the weekly injection is convenient. Rybelsus is useful if you prefer an oral tablet or have a needle aversion. With generic semaglutide now available in Canada (Dr. Reddy's and Apotex), expect your prescription to be switchable. See our Ozempic in Newfoundland and Labrador guide for province-specific diabetes coverage details.
If you have obesity and a BMI of 30 or higher
Wegovy is the Health Canada-approved product. NLPDP does not cover Wegovy, so your best path to a lower monthly cost is private insurance with prior authorization. Some patients use off-label Ozempic because it is cheaper, but the 2.4 mg dose is only validated in the STEP trials for Wegovy. See our Wegovy in Newfoundland and Labrador guide for province-specific weight-loss prior-auth details.
If you want the cheapest legal option
Consider generic semaglutide. It launched in Canadian pharmacies in May 2026 at about $88 to $120 per month for the diabetes dose [3]. Generic semaglutide (Apo-Semaglutide from Apotex, Dr. Reddy's generic) is now the cheapest cash option in Newfoundland and Labrador at roughly $88 to $99 per month at Costco Pharmacy, well below brand Ozempic at $250 to $310.
Generic Semaglutide Launch in Newfoundland and Labrador
Novo Nordisk’s Canadian data exclusivity on semaglutide expired on January 4, 2026 [4]. Health Canada has now authorized two generic manufacturers, Dr. Reddy's Laboratories (April 28, 2026) and Apotex Inc. (May 1, 2026). Additional applications from Sandoz, Teva Canada and other manufacturers remain under review. Both reached Canadian pharmacies in the type 2 diabetes indication (Ozempic-equivalent) in May 2026, followed by a 2.4 mg weight-management generic in late 2026 or early 2027, with generic cash prices expected to ease further as more manufacturers launch and several provinces review the generic for public-plan coverage [3].
The Shoppers Drug Mart and Lawtons networks, along with Costco St. John’s, are expected to lead generic semaglutide stocking in NL. Expect a 30 to 45 day lag vs mainland provinces for independents.
For the national timeline and manufacturer detail, read our generic semaglutide guide.
Compounded Semaglutide: Not a Legal Option in Newfoundland and Labrador
Health Canada prohibits the compounding of semaglutide by community pharmacies [5]. Any website or clinic advertising "compounded semaglutide" in Newfoundland and Labrador is operating outside Canadian drug-safety regulation. Product purity, sterility and potency cannot be verified. Serious adverse events have been reported in the U.S. from compounded GLP-1 use.
- Compounded semaglutide has not been reviewed by Health Canada for safety, quality or efficacy.
- Health Canada issued public warnings against compounded weight-loss drugs in 2023 and 2024.
- Provincial colleges of pharmacists in Newfoundland and Labrador prohibit licensed pharmacies from dispensing compounded semaglutide.
If you encounter a telehealth service offering "compounded semaglutide" in Newfoundland and Labrador, it is either (a) not operating legally in Canada or (b) referring you to an unregulated U.S. source. Stick with Health Canada-approved Ozempic, Wegovy, Rybelsus or now-available generic semaglutide.
Telehealth vs In-Person Semaglutide in Newfoundland and Labrador
Both paths are widely available to Newfoundlanders and Labradorians. Here’s how the six Canadian telehealth services compare.
Top pick: MyRocky (operated by Rocky Health Inc.) is our highest-rated Canadian GLP-1 provider in 2026 (9.4/10). Per-pen pricing is roughly comparable across the major Canadian telehealth services - what MyRocky wins on is total value: the $99 one-time consult includes lab work and the first prescription, there are no recurring quarterly fees, free fast delivery is included, and it operates its own LegitScript-certified pharmacy in Mississauga. MyRocky also serves all 10 provinces (Felix and Hims do not operate in Quebec) and has been trusted by 350,000+ Canadians. Visit MyRocky or read our full MyRocky review.
| Provider | Monthly Program Cost | Consultation Fee | Coverage | Learn More |
|---|---|---|---|---|
| MyRocky ⭐ Top Pick | $300–$310 | $99 once (lab work included) | All 10 provinces | Visit MyRocky |
| Felix Health | Brand $250–$310 / Generic $149 | $99 setup + $40 quarterly | All provinces except QC | Visit Felix |
| Maple | $270–$320 | $69 per consult | All provinces | Visit Maple |
| Hims Canada | Generic $149 all-in | Included | Select provinces | Visit Hims |
| Jill Health | Pricing on assessment | Included in program | Most provinces | Visit Jill |
| DooU | Pricing on assessment | Included in program | Most provinces | Visit DooU |
| Raven | Pricing on assessment | Included in program | Most provinces | Visit Raven |
Provider reviews: MyRocky (top pick), Felix, Maple, Hims Canada, Jill Health, DooU and Raven.
All six telehealth services on this list accept new patients from Newfoundland and Labrador as of April 2026.
Cost of Semaglutide in Newfoundland and Labrador
Your monthly cost depends on which product you take and where you fill it. Quick overview for Newfoundland and Labrador:
- Ozempic 1.0 mg: $250 to $375 per month brand cash; Costco is cheapest at about $255 to $270 in most Newfoundland and Labrador cities.
- Wegovy 2.4 mg: $540 to $570 per month brand cash; Costco is cheapest at $495 to $525.
- Rybelsus 14 mg: $250 to $300 per month brand cash; similar to Ozempic pricing.
- Generic semaglutide (now available for diabetes): $88 to $120 per month depending on indication and dose.
For in-depth pharmacy-by-pharmacy pricing, see the brand-specific pages: Ozempic in Newfoundland and Labrador and Wegovy in Newfoundland and Labrador. For national pricing comparison, see our semaglutide cost guide.
Clinical Evidence Behind Semaglutide for Newfoundlanders and Labradorians
Semaglutide has the strongest randomized-trial evidence base of any GLP-1 receptor agonist. Key studies that inform prescribing in Newfoundland and Labrador:
- SUSTAIN-6 (2016). Injectable semaglutide (Ozempic) reduced major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [6].
- STEP 1 (2021). Semaglutide 2.4 mg (Wegovy) produced a mean weight loss of roughly 14.9 percent over 68 weeks in adults with obesity, vs 2.4 percent on placebo [7].
- SELECT (2023). Semaglutide 2.4 mg reduced major adverse cardiovascular events by 20 percent in adults with overweight or obesity and established cardiovascular disease, without type 2 diabetes [8].
- PIONEER program. Oral semaglutide (Rybelsus) showed non-inferior HbA1c reduction vs injectable in type 2 diabetes patients, at the cost of a small absorption window around dosing.
FAQ
Is semaglutide the same as Ozempic in Newfoundland and Labrador?
Semaglutide is the active ingredient. Ozempic is a Health Canada-approved brand of injectable semaglutide for type 2 diabetes. Wegovy is the higher-dose brand for weight management. Rybelsus is the oral tablet. All three are sold across Newfoundland and Labrador.
Is generic semaglutide available in Newfoundland and Labrador?
Yes. Apotex's Apo-Semaglutide Injection and Dr. Reddy's generic launched in Canadian pharmacies in May 2026, with Costco the lowest cash price at roughly $88 to $99 per month. The 2.4 mg weight-management dose (Wegovy-equivalent) is still expected in late 2026 or early 2027.
Can I buy compounded semaglutide in Newfoundland and Labrador?
No. Health Canada and provincial colleges of pharmacists prohibit compounded semaglutide. Any service offering it in Newfoundland and Labrador is operating outside Canadian drug-safety regulation. Stick with Health Canada-approved Ozempic, Wegovy, Rybelsus or the now-available generic.
Which semaglutide product is cheapest in Newfoundland and Labrador today?
For type 2 diabetes, Ozempic at Costco pharmacy runs about $255 to $270 per month in Newfoundland and Labrador. For weight management, Wegovy at Costco runs $495 to $525 per month. Generic semaglutide already undercuts both, available since May 2026.
Is oral semaglutide (Rybelsus) covered by NLPDP?
NLPDP lists Rybelsus as Special Authorization for type 2 diabetes. Coverage conditions mirror those for injectable Ozempic. Weight-management use is never covered.
How has semaglutide supply in Newfoundland and Labrador changed since 2024?
St. John’s and Corner Brook pharmacies faced tighter supply conditions than mainland Canada through 2023 and 2024, given distribution logistics. Supply has been consistent since Q2 2025.
Can a telehealth service prescribe any semaglutide product in Newfoundland and Labrador?
Yes, in most cases. Newfoundlanders and Labradorians can access Ozempic, Wegovy and Rybelsus through Canadian telehealth services after an online assessment. All six Canadian telehealth services on this list serve Newfoundland and Labrador.
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing directly with the pharmacy before filling.
Sources
- Health Canada: Semaglutide (Ozempic, Wegovy, Rybelsus) Product Monographs: Official Canadian product monographs for all three Health Canada-approved semaglutide brands.
- Newfoundland and Labrador Prescription Drug Program: Official Program Information: Provincial drug plan rules and formulary lookup for Newfoundland and Labrador.
- Patented Medicine Prices Review Board: Generic Drug Pipeline (2026): Industry reporting on generic semaglutide submissions under Health Canada review.
- Semaglutide Canada: Generic Semaglutide in Canada: Full national timeline on generic semaglutide launch, manufacturers and pricing.
- Health Canada: Advisory on Compounded Semaglutide and Other Weight-Loss Products: Public warnings on unauthorized compounded semaglutide products and related safety concerns.
- SUSTAIN-6: Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes (NEJM, 2016): Landmark cardiovascular outcomes trial for Ozempic.
- STEP 1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM, 2021): Landmark randomized trial establishing Wegovy efficacy for chronic weight management.
- SELECT: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (NEJM, 2023): Landmark trial showing cardiovascular benefit of Wegovy in non-diabetic adults with obesity.
- Drug Shortages Canada: Health Canada-run site tracking current semaglutide supply status across Canada.
- Canadian Agency for Drugs and Technologies in Health (CADTH): Semaglutide Reimbursement Review: CADTH reimbursement guidance used by provincial drug plans for semaglutide.